Prediction Of Asthma Symptom Burden In Subjects Dispensed Low/Moderate Dose Fluticasone Propionate/Salmeterol (FSC) or Moderate/High Dose Fluticasone Propionate (FP) in Subjects Without History of ICS Use

To estimate the frequency of asthma symptoms among managed care enrollees newly prescribed low/moderate dose fluticasone propionate/salmeterol (FSC) or moderate/high dose fluticasone propionate (FP) with no prior claims of inhaled corticosteroids (ICS) within 3 years.

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 125; no. 2; p. AB71
Main Authors Stanford, R.H., Riedel, A., Burke, J., Borah, B., Kulakodlu, M.
Format Journal Article
LanguageEnglish
Published St. Louis Mosby, Inc 2010
Elsevier Limited
Subjects
Allergy and Immunology
Asthma
Medical research
Online AccessGet full text
ISSN0091-6749
1097-6825
DOI10.1016/j.jaci.2009.12.279

Cover

More Information
Summary:To estimate the frequency of asthma symptoms among managed care enrollees newly prescribed low/moderate dose fluticasone propionate/salmeterol (FSC) or moderate/high dose fluticasone propionate (FP) with no prior claims of inhaled corticosteroids (ICS) within 3 years.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2009.12.279